Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Plos One|October 7, 2015
Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin ESebastian Miethe, Christine Rasetti-Escargueil, Arnaud Avril, et al.Mabs|December 18, 2014
Effect of formulation on the stability and aerosol performance of a nebulized antibodyRenaud Respaud, Denis Marchand, Christelle Parent, et al.Plos One|June 6, 2012
Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivoTorsten Rülker, Luzie Voß, Philippe Thullier, et al.Mabs|September 19, 2015
Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype BChristine Rasetti-Escargueil, Arnaud Avril, Siham Chahboun, et al.Plos One|August 14, 2009
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatusMark Schütte, Philippe Thullier, Thibaut Pelat, et al.Emerging Infectious Diseases|May 3, 2011
Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the CongoEric Bertherat, Philippe Thullier, Jean Christophe Shako, et al.Mabs|March 14, 2017
Generation and characterization of protective antibodies to Marburg virusJeffrey W Froude, Thibaut Pelat, Sebastian Miethe, et al.Toxins|October 5, 2017
The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum AntibodiesChristine Rasetti-Escargueil, Arnaud Avril, Sebastian Miethe, et al.Plos One|August 26, 2016
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and BSebastian Miethe, Christelle Mazuet, Yvonne Liu, et al.Toxins|September 15, 2016
Neutralization of Botulinum Neurotoxin Type E by a Humanized AntibodyYağmur Derman, Katja Selby, Sebastian Miethe, et al.Pageof 5